Essex Bio-Technology Limited (HK:1061)
:1061
Total Valuation
Essex Bio-Technology has a market cap or net worth of HK$2.01B. The enterprise value is HK$1.58B.
Market CapHK$2.01B
Enterprise ValueHK$1.58B
Share Statistics
Essex Bio-Technology has 567,006,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding567,006,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Essex Bio-Technology’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 11.27%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)11.27%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee1.25M
Profits Per Employee285.97K
Employee Count1,450
Asset Turnover0.52
Inventory Turnover2.47
Valuation Ratios
The current PE Ratio of Essex Bio-Technology is 6.7. Essex Bio-Technology’s PEG ratio is 1.81.
PE Ratio6.7
PS Ratio1.18
PB Ratio0.89
Price to Fair Value0.89
Price to FCF16.23
Price to Operating Cash Flow6.70
PEG Ratio1.81
Income Statement
In the last 12 months, Essex Bio-Technology had revenue of 1.81B and earned 318.09M in profits. Earnings per share was 0.56.
Revenue1.81B
Gross Profit1.62B
Operating Income410.48M
Pretax Income414.66M
Net Income318.09M
EBITDA410.48M
Earnings Per Share (EPS)0.56
Cash Flow
In the last 12 months, operating cash flow was 306.32M and capital expenditures -174.61M, giving a free cash flow of 131.71M billion.
Operating Cash Flow306.32M
Free Cash Flow131.71M
Free Cash Flow per Share0.23
Dividends & Yields
Essex Bio-Technology pays an annual dividend of HK$0.07, resulting in a dividend yield of 3.37%
Dividend Per ShareHK$0.07
Dividend Yield3.37%
Payout Ratio23.55%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change-11.91%
50-Day Moving Average4.03
200-Day Moving Average4.53
Relative Strength Index (RSI)35.46
Average Volume (3m)863.25K
Important Dates
Essex Bio-Technology upcoming earnings date is Aug 25, 2026, TBA (Confirmed).
Last Earnings DateMar 23, 2026
Next Earnings DateAug 25, 2026
Ex-Dividend Date―
Financial Position
Essex Bio-Technology as a current ratio of 2.11, with Debt / Equity ratio of 14.38%
Current Ratio2.11
Quick Ratio2.01
Debt to Market Cap0.15
Net Debt to EBITDA-1.06
Interest Coverage Ratio52.52
Taxes
In the past 12 months, Essex Bio-Technology has paid 96.57M in taxes.
Income Tax96.57M
Effective Tax Rate0.23
Enterprise Valuation
Essex Bio-Technology EV to EBITDA ratio is 4.15, with an EV/FCF ratio of 12.92.
EV to Sales0.94
EV to EBITDA4.15
EV to Free Cash Flow12.92
EV to Operating Cash Flow5.56
Balance Sheet
Essex Bio-Technology has HK$784.14M in cash and marketable securities with HK$346.90M in debt, giving a net cash position of HK$437.24M billion.
Cash & Marketable SecuritiesHK$784.14M
Total DebtHK$346.90M
Net CashHK$437.24M
Net Cash Per ShareHK$0.77
Tangible Book Value Per ShareHK$1.92
Margins
Gross margin is 89.20%, with operating margin of 22.63%, and net profit margin of 17.54%.
Gross Margin89.20%
Operating Margin22.63%
Pretax Margin22.86%
Net Profit Margin17.54%
EBITDA Margin22.63%
EBIT Margin22.63%
Analyst Forecast
The average price target for Essex Bio-Technology is HK$6.84, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$6.84
Price Target Upside79.53% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast7.16%
EPS Growth Forecast19.19%